MedPath

A prospective randomized controlled trial of AJG522 versus standard PEG plus E as bowel preparation for colonoscopy

Phase 4
Conditions
lcerative colitis and so on
Registration Number
JPRN-UMIN000013892
Lead Sponsor
Gunma University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

Subjects had any of the following: a history of colonic resection; ileus; gastrointestinal obstruction or perforation; severe inflammatory bowel disease, such as toxic megacolon; heart failure (New York Heart Association [NYHA] Class III or IV); acute life-threatening cardiovascular disease; untreated or uncontrolled hypertension; severe liver failure; severe psychosomatic disease; or end-stage renal insufficiency. Hospitalized patients

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The fecal properties as a bowel cleansing condition for the colonoscopy via the macroscopic observation of stool.
Secondary Outcome Measures
NameTimeMethod
Taste, acceptability, willingness to repeat, patient satisfaction, and adverse events
© Copyright 2025. All Rights Reserved by MedPath